POMYELO 2 MG TAB. 1X21 TAB.

About

Pomalidomide is an immunomodulatory drug (IMiD) primarily used in the treatment of multiple myeloma. It is indicated for adult patients with relapsed and refractory multiple myeloma who have received at least two prior therapies, including lenalidomide and bortezomib, and have demonstrated disease progression on or within 60 days of completion of the last therapy. Pomalidomide exerts its anti-myeloma effects through multiple mechanisms, including direct cytotoxicity to tumor cells, inhibition of angiogenesis, and enhancement of host anti-tumor immunity. It also modulates the immune system by enhancing T-cell and natural killer (NK) cell activity while inhibiting the production of pro-inflammatory cytokines. Due to its teratogenic potential, strict risk management programs are in place for its prescription and dispensing.

Uses

• Treatment of relapsed and refractory multiple myeloma.
• For patients who have received prior specific therapies.
• Inhibition of angiogenesis in tumor microenvironment.
• Enhancement of host anti-tumor immunity.

Directions For Use

Take orally once daily with water, with or without food, as prescribed by your doctor. Do not break or chew.

Benefits

• Effective in relapsed/refractory multiple myeloma.
• Multiple mechanisms of action against cancer cells.
• Modulates the immune system to fight cancer.
• Oral administration for patient convenience.
• Can be used in combination with other therapies.
• Offers a treatment option for difficult-to-treat cases.

Side Effects

• Fatigue
• Neutropenia
• Thrombocytopenia
• Anemia
• Constipation
• Diarrhea
• Nausea
• Peripheral neuropathy
• Dyspnea
• Pneumonia
• Deep vein thrombosis
• Pulmonary embolism

Safety Measures

• Alcohol - Avoid or limit alcohol due to potential for increased drowsiness or liver strain.
• Pregnancy - Absolutely contraindicated due to severe teratogenic risk; strict contraception required.
• Breastfeeding - Not recommended due to potential harm to the infant; discontinue breastfeeding.
• Liver - Use with caution in hepatic impairment; dose adjustments may be necessary.
• Kidney - Use with caution in renal impairment; dose adjustments may be necessary.
• Lung - Monitor for new or worsening pulmonary symptoms, including dyspnea or cough.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.